Telovance
preclinicalplatform · high
Safely lengthen shortened telomeres during ex-vivo cell therapy manufacturing to extend replicative lifespan, improve cytotoxicity, and reduce cell exhaustion in manufactured cell therapies.
Recombinant protein or protein complex delivered during ex-vivo cell therapy manufacturing, aimed at telomere lengthening in therapeutic cells such as CAR-T or other cell therapy products.
Telos Biotech was launched by Cambrian Bio in 2020 to develop Telovance based on work from Jerry Shay, Enzo Tedone, and Mohammad Sayed at UT Southwestern.